Prospect Capital Corp (PSEC) concluded trading on Thursday at a closing price of $4.32, with 3.24 million shares of worth about $14.02 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.59% during that period and on January 30, 2025 the price saw a gain of about 1.65%. Currently the company’s common shares owned by public are about 436.18M shares, out of which, 310.15M shares are available for trading.
Stock saw a price change of -1.14% in past 5 days and over the past one month there was a price change of 1.41%. Year-to-date (YTD), PSEC shares are showing a performance of 0.23% which decreased to -29.87% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.09 but also hit the highest price of $6.15 during that period. The average intraday trading volume for Prospect Capital Corp shares is 3.76 million. The stock is currently trading 0.05% above its 20-day simple moving average (SMA20), while that difference is down -2.22% for SMA50 and it goes to -15.29% lower than SMA200.
Prospect Capital Corp (NASDAQ: PSEC) currently have 436.18M outstanding shares and institutions hold larger chunk of about 9.15% of that.
The stock has a current market capitalization of $1.88B and its 3Y-monthly beta is at 0.98. It has posted earnings per share of -$0.25 in the same period. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PSEC, volatility over the week remained 1.47% while standing at 1.64% over the month.
Stock’s fiscal year EPS is expected to drop by -47.06% while it is estimated to decrease by -12.96% in next year.
Coverage by Wells Fargo stated Prospect Capital Corp (PSEC) stock as an Underweight in their note to investors on June 25, 2020, suggesting a price target of $4.50 for the stock. On April 20, 2020, Raymond James Downgrade their recommendations, while on January 22, 2019, Barclays Downgrade their ratings for the stock with a price target of $6. Stock get a Mkt perform rating from Raymond James on August 30, 2017.
